INTERNATIONAL PATENT: UCB BIOPHARMA SRL FILES APPLICATION FOR "IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS"

GENEVA, April 13 -- UCB BIOPHARMA SRL (Allee de la Recherche 601070 Brussels) filed a patent application (PCT/EP2025/078039) for "IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS" on Sep 30, 2025. With publication no. WO/2026/073937, the details related to the patent application was published on Apr 09, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BROOKINGS, Daniel Christopher (c/o IPDUCB208 Bath RoadSlough Berkshire SL1 3WE), BRUFFAERTS, Jeffrey (c/o IPDUCB208 Bath RoadSlough Berkshire SL1 3WE)

Abstract: Cyclopropyl N-[(S)-[3-[1-(2,2-difluoropropylcarbamoyl)-3-hydroxy-3-methyl- cyclobuty...